Hemispherx BioPharma (HEB)

[COINSTRADERS]

Analysist states sustainable corporate profitability 2016 HEB
From JJs post[color=red][color=red][/color][/color]

Investment Thesis
1) Alferon N Injection is a commercially ready FDA-approved product
for treating refractory/recurring HPV genital warts. It has
advantages over recombinant interferon: greater potency, fewer
side effects and far lower incidence of neutralizing antibodies. We
forecast potential revenue of about $70-100M in 2016 and the
start of sustainable corporate profitability.

This is why our thieves are Manipulating and stealing here they want all your shares so they can become rich and you can become poorer!

Just Look at all the bashing they dumped a bunch of money here last 2 days to steal your money!